This inventor holds 1 USPTO granted patent. Top assignees: Hitachi Chemical Company America, Ltd., Hitachi Chemical Company, Ltd., The Cleveland Clinic Foundation. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2015
Title: The Innovations of Ernest C. Borden
Introduction
Ernest C. Borden is a notable inventor based in Cleveland, Ohio. He has made significant contributions to the field of biotechnology, particularly in the area of interferon responsiveness. His work has implications for both therapeutic applications and the understanding of individual responses to treatment.
Latest Patents
Borden holds a patent titled "Methods of characterizing host responsiveness to interferon by ex vivo induction of interferon-responsive markers." This invention relates to methods for quantifying the expression of interferon-responsive genes. It also characterizes an individual's potential responsiveness to interferon administration. The patent outlines methods to monitor the efficacy of ongoing interferon therapy by evaluating the expression of these genes before and after treatment.
Career Highlights
Throughout his career, Borden has worked with prominent companies in the industry. He has been associated with Hitachi Chemical Company, Ltd. and Hitachi Chemical Company America, Ltd. His experience in these organizations has contributed to his expertise in biotechnology and patent development.
Collaborations
Borden has collaborated with various professionals in his field, including Masato Mitsuhashi. These collaborations have likely enhanced his research and development efforts, leading to innovative solutions in biotechnology.
Conclusion
Ernest C. Borden's contributions to the field of biotechnology through his patent on interferon responsiveness highlight his role as an influential inventor. His work continues to impact the understanding and treatment of diseases related to interferon therapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile